October 4, 2016 / 10:37 AM / 10 months ago

BRIEF-Trovagene selected as liquid biopsy provider

1 Min Read

Oct 4 (Reuters) - Trovagene Inc

* Selected as liquid biopsy provider to participate in first large-scale precision medicine trial for patients with pancreatic cancer

* Selected by Pancreatic Cancer Action Network as liquid biopsy provider to participate in precision medicine trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below